Oramed Pharmaceuticals Inc. Common Stock (ORMP)

$3.8 +2.15%
EARNINGS ANALYTICS
search

Oramed Pharmaceuticals Inc. Common Stock (ORMP) has only 2 recorded earnings events on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was +14.76% (Nov 10, 2022) and its biggest decline was -2.1% (Nov 17, 2025).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

2

Avg Abs. Movement

±8.43%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date Timing Open High Close Volume Movement % SEC Filing
Nov 17, 2025 ☀ PRE $2.32 $2.34 $2.33 18,477 -2.1% open_in_new
Nov 10, 2022 ☽ POST $6.64 $6.71 $6.57 5,827 +14.76% open_in_new
event

Earnings Count

2

Total earnings in dataset

trending_up

Avg Abs. Movement

±8.43%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

5 most recent
Form Date Filed View on EDGAR
10-Q 20260519 open_in_new SEC.gov
NT 10-Q 20260515 open_in_new SEC.gov
SCHEDULE 13G 20260515 open_in_new SEC.gov
3 20260514 open_in_new SEC.gov
SCHEDULE 13D 20260514 open_in_new SEC.gov

Frequently asked about ORMP earnings

How much does ORMP stock move after earnings? expand_more

Over 2 reports, ORMP has moved an average of ±8.43% the session after earnings, closing higher 50.0% of the time.

What was ORMP's biggest post-earnings move? expand_more

ORMP's largest post-earnings gain on record was +14.76% on Nov 10, 2022, and its largest decline was -2.1% on Nov 17, 2025.

Where can I find Oramed Pharmaceuticals Inc. Common Stock's SEC filings? expand_more

All of Oramed Pharmaceuticals Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers